Skip to main content
Clinical Trials/DRKS00013512
DRKS00013512
Completed
未知

Influence of retrograde autologous priming (RAP) on the safety and efficacy of cardiopulmonary bypass (CPB) and transfusion requirements

niversitätsklinikum Halle (Saale)Klinik und Poliklinik für Herzchirurgie0 sites118 target enrollmentDecember 4, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
I25.1
Sponsor
niversitätsklinikum Halle (Saale)Klinik und Poliklinik für Herzchirurgie
Enrollment
118
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 4, 2017
End Date
October 21, 2015
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Halle (Saale)Klinik und Poliklinik für Herzchirurgie

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient is older than 18 years.
  • 2\. Patient has coronary heart disease or aortic valve defect and is a suitable candidate for cardiopulmonary bypass (CPB) surgery.
  • 3\. Patient has been informed about the study and has given his written consent.

Exclusion Criteria

  • 1\. Ejection fraction \= 20%
  • 2\. Re\-operation
  • 3\. Acute endocarditis
  • 4\. Acute myocardial infarction within 24 hours before the procedure, calculated on the onset of symptoms.
  • 5\. Known pre\-operative presence of intracardiac thrombi
  • 6\. Stenosis of an internal carotid artery \> 70%
  • 7\. Dialysis
  • 8\. Malignant disease or immunological diseases
  • 9\. Taking Marcumar, preoperative continuous heparin infusion or known coagulopathy
  • 10\. Thrombocytopenia (\<100 Gpt/l)

Outcomes

Primary Outcomes

Not specified

Similar Trials